Cargando…
A Case of Immune Checkpoint Inhibitor-Induced Probable Myocarditis and Treatment Response
Immune checkpoint inhibitors (ICI) are a new class of pharmaceuticals that facilitate the immune system in identifying and targeting cancerous cells. However, suppressing immune regulation can often cause immune-mediated adverse events. One such downstream effect recently recognized is ICI-associate...
Autores principales: | Hassan, Mubariz A, Batta, Yashvardhan, Afzal, Muhammad Adil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310539/ https://www.ncbi.nlm.nih.gov/pubmed/37398769 http://dx.doi.org/10.7759/cureus.39692 |
Ejemplares similares
-
Chemotherapy-Induced Atrial Fibrillation With Rapid Ventricular Response in a Patient With Pleomorphic Rhabdomyosarcoma: A Case Report and Approach to Management
por: Hassan, Mubariz A, et al.
Publicado: (2023) -
Non-ST Segment Elevation Myocardial Infarction (NSTEMI) in the Setting of Severe Rhabdomyolysis and COVID-19 Infection: A Case Report
por: Hassan, Mubariz A, et al.
Publicado: (2023) -
Two Cases of Immune Checkpoint Inhibitor-Induced Myocarditis With Complete Atrioventricular Block
por: Kondo, Hisaya, et al.
Publicado: (2023) -
A Systematic Review of Myocarditis Induced by Immune Checkpoint Inhibitors: How Concerning Is the Most Common Cardiotoxicity of Immune Checkpoint Inhibitors?
por: Moradi, Ali, et al.
Publicado: (2023) -
A Case of Amitriptyline-induced Myocarditis
por: Kassim, Thamer, et al.
Publicado: (2018)